| Drug Type Biosimilar, Monoclonal antibody | 
| Synonyms TX-17, TX17 | 
| Target | 
| Action inhibitors | 
| Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPreclinical | 
| First Approval Date- | 
| Regulation- | 


| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Rheumatoid Arthritis | Preclinical | Taiwan Province  | - | 






